Suggest "Bridging" Fewer Warfarin Patients With Enoxaparin

August 2015

You'll see LESS use of "bridging" with low-molecular-weight heparin (enoxaparin, etc) in warfarin patients.

Up to 1 in 6 patients are bridged with an injectable anticoagulant when warfarin is temporarily stopped before surgery or a procedure...hoping to prevent a clot or stroke.

But evidence from the new BRIDGE trial will be a game changer. It suggests that bridging does more harm than good in many patients.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote